Description
DECREASE AND CLOSEOUT OF PO FOR HUMAN BLOOD & BLOOD PRODUCTS
Base award description: HUMAN BLOOD&BLOOD PRODUCTS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-01+$512,500= $512,500
- Mod P000012019-10-01+$120,000= $632,500
- Mod P000022022-05-03-$5,556= $626,944
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-01 | +$512,500 | $512,500 | HUMAN BLOOD&BLOOD PRODUCTS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-10-01 | +$120,000 | $632,500 | HUMAN BLOOD&BLOOD PRODUCTS |
| Mod P00002· FUNDING ONLY ACTION | 2022-05-03 | −$5,556 | $626,944 | DECREASE AND CLOSEOUT OF PO FOR HUMAN BLOOD & BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GKT4L2JZJ622)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026D0056 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY | $0 | FY2026 |
| 36C26026N0391 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY | $70,000 | FY2026 |
| 36C24426N0344 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $1,682,246 | FY2026 |
| 36C24426D0025 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C24426N0788 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q999 · MEDICAL- OTHER | $56,268 | FY2026 |
| 36C26126N0359 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $123,337 | FY2026 |
Other recipients under 6505 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25926F0310 | JANSSEN BIOTECH INC | NETWORK CONTRACT OFFICE 19 (36C259) | $384,719 | FY2026 |
| 36C25926N0409 | MEDI-PHYSICS, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $34,735 | FY2026 |
| 36C25926F0264 | JANSSEN BIOTECH INC | NETWORK CONTRACT OFFICE 19 (36C259) | $384,719 | FY2026 |
| 36C25926N0384 | SIRTEX MEDICAL INC | NETWORK CONTRACT OFFICE 19 (36C259) | $245,194 | FY2026 |
| 36C25926P0553 | COSETTE PHARMACEUTICALS, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $3,439 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25920N0015_3600_36C25919A0002_3600 · retrieved 2026-09-26.